SIC: 2834 - PHARMACEUTICAL PREPARATIONS
State location: NY | Fiscal Year End: 0331
formerly: Axovant Gene Therapies Ltd. (filings through 2020-11-13)
formerly: Axovant Sciences Ltd. (filings through 2019-04-18)
formerly: Roivant Neurosciences Ltd. (filings through 2015-03-24)
Get insider transactions for this issuer.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 15-12G | Documents | Securities registration termination [Section 12(g)] Acc-no: 0001636050-23-000028 (34 Act) Size: 17 KB |
2023-04-25 | 001-37418 23844836 |
| EFFECT | Documents | Notice of Effectiveness Acc-no: 9999999995-23-001018 (33 Act) Size: 1 KB |
2023-04-24 | 333-235889 23841501 |
| POS AM | Documents | Post-Effective amendments for registration statement Acc-no: 0001636050-23-000026 (33 Act) Size: 30 KB |
2023-04-17 | 333-235889 23824129 |
| S-8 POS | Documents | Securities to be offered to employees in employee benefit plans, post-effective amendments Acc-no: 0001636050-23-000024 (33 Act) Size: 30 KB |
2023-04-17 | 333-260100 23824083 |
| 25-NSE | Documents | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Acc-no: 0001354457-23-000271 (34 Act) Size: 3 KB |
2023-04-12 | 001-37418 |
| 25 | Documents | Notification of the removal from listing and registration of matured, redeemed or retired securities Acc-no: 0001636050-23-000017 (34 Act) Size: 17 KB |
2023-04-06 | 001-37418 23806230 |
| 8-K | Documents Interactive Data | Current report, items 5.02 and 5.07
Acc-no: 0001636050-23-000016 (34 Act) Size: 208 KB |
2023-04-06 | 001-37418 23806215 |
| DEFA14A | Documents | Additional definitive proxy soliciting materials and Rule 14(a)(12) material Acc-no: 0001636050-23-000013 (34 Act) Size: 33 KB |
2023-03-17 | 001-37418 23740556 |
| 8-K | Documents Interactive Data | Current report, item 3.01
Acc-no: 0001636050-23-000011 (34 Act) Size: 202 KB |
2023-03-15 | 001-37418 23735568 |
| DEFM14A | Documents | Definitive proxy statement relating to merger or acquisition Acc-no: 0001140361-23-007830 (34 Act) Size: 2 MB |
2023-02-21 | 001-37418 23648060 |
| DEFA14A | Documents | Additional definitive proxy soliciting materials and Rule 14(a)(12) material Acc-no: 0001636050-23-000009 (34 Act) Size: 170 KB |
2023-02-14 | 001-37418 23622242 |
| 8-K | Documents Interactive Data | Current report, items 2.02 and 9.01
Acc-no: 0001636050-23-000008 (34 Act) Size: 370 KB |
2023-02-14 | 001-37418 23622227 |
| 10-Q | Documents Interactive Data | Quarterly report [Sections 13 or 15(d)] Acc-no: 0001636050-23-000007 (34 Act) Size: 3 MB |
2023-02-14 | 001-37418 23622144 |
| SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0000919574-23-000939 (34 Act) Size: 107 KB |
2023-02-13 | 005-88883 23614986 |
| SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0001104659-23-018477 (34 Act) Size: 75 KB |
2023-02-10 | 005-88883 23611629 |
| PREM14A | Documents | Preliminary proxy statements relating to merger or acquisition Acc-no: 0001140361-23-005279 (34 Act) Size: 2 MB |
2023-02-09 | 001-37418 23600307 |
| DEFA14A | Documents | Additional definitive proxy soliciting materials and Rule 14(a)(12) material Acc-no: 0001636050-22-000056 (34 Act) Size: 91 KB |
2022-12-14 | 001-37418 221462226 |
| 8-K | Documents Interactive Data | Current report, items 8.01 and 9.01
Acc-no: 0001636050-22-000054 (34 Act) Size: 303 KB |
2022-12-14 | 001-37418 221462146 |
| 8-K | Documents Interactive Data | Current report, items 2.02 and 9.01
Acc-no: 0001636050-22-000051 (34 Act) Size: 373 KB |
2022-11-10 | 001-37418 221374867 |
| 10-Q | Documents Interactive Data | Quarterly report [Sections 13 or 15(d)] Acc-no: 0001636050-22-000050 (34 Act) Size: 3 MB |
2022-11-10 | 001-37418 221374859 |
| 8-K | Documents Interactive Data | Current report, item 3.01
Acc-no: 0001636050-22-000043 (34 Act) Size: 188 KB |
2022-09-14 | 001-37418 221243097 |
| 8-K | Documents Interactive Data | Current report, items 2.02 and 9.01
Acc-no: 0001636050-22-000041 (34 Act) Size: 272 KB |
2022-08-11 | 001-37418 221153629 |
| 10-Q | Documents Interactive Data | Quarterly report [Sections 13 or 15(d)] Acc-no: 0001636050-22-000040 (34 Act) Size: 3 MB |
2022-08-11 | 001-37418 221153621 |
| 8-K | Documents Interactive Data | Current report, items 2.02 and 9.01
Acc-no: 0001636050-22-000036 (34 Act) Size: 287 KB |
2022-06-14 | 001-37418 221013417 |
| 10-K | Documents Interactive Data | Annual report [Section 13 and 15(d), not S-K Item 405] Acc-no: 0001636050-22-000035 (34 Act) Size: 6 MB |
2022-06-14 | 001-37418 221013415 |
| 8-K | Documents Interactive Data | Current report, items 1.02, 2.02, 2.05, 7.01, and 9.01
Acc-no: 0001636050-22-000031 (34 Act) Size: 233 KB |
2022-04-27 | 001-37418 22860311 |
| 8-K | Documents Interactive Data | Current report, item 3.01
Acc-no: 0001636050-22-000027 (34 Act) Size: 187 KB |
2022-03-18 | 001-37418 22752822 |
| SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0001085146-22-001038 (34 Act) Size: 46 KB |
2022-02-14 | 005-88883 22629195 |
| SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0000919574-22-000910 (34 Act) Size: 121 KB |
2022-02-11 | 005-88883 22621996 |
| 8-K | Documents Interactive Data | Current report, items 2.02 and 9.01
Acc-no: 0001636050-22-000025 (34 Act) Size: 310 KB |
2022-02-11 | 001-37418 22616666 |
| 10-Q | Documents Interactive Data | Quarterly report [Sections 13 or 15(d)] Acc-no: 0001636050-22-000024 (34 Act) Size: 4 MB |
2022-02-11 | 001-37418 22616655 |
| 8-K | Documents Interactive Data | Current report, items 7.01 and 9.01
Acc-no: 0001636050-22-000015 (34 Act) Size: 2 MB |
2022-02-09 | 001-37418 22603764 |
| 8-K/A | Documents Interactive Data | [Amend] Current report, item 5.07
Acc-no: 0001636050-22-000011 (34 Act) Size: 185 KB |
2022-01-31 | 001-37418 22574188 |
| 8-K | Documents Interactive Data | Current report, items 2.02, 5.02, 7.01, 8.01, and 9.01
Acc-no: 0001636050-22-000009 (34 Act) Size: 261 KB |
2022-01-31 | 001-37418 22574035 |
| 8-K | Documents Interactive Data | Current report, item 5.02
Acc-no: 0001636050-22-000002 (34 Act) Size: 184 KB |
2022-01-25 | 001-37418 22554560 |
| 8-K | Documents Interactive Data | Current report, items 2.02 and 9.01
Acc-no: 0001636050-21-000095 (34 Act) Size: 318 KB |
2021-11-12 | 001-37418 211399473 |
| 10-Q | Documents Interactive Data | Quarterly report [Sections 13 or 15(d)] Acc-no: 0001636050-21-000094 (34 Act) Size: 4 MB |
2021-11-12 | 001-37418 211399452 |
| 8-K | Documents Interactive Data | Current report, items 7.01, 8.01, and 9.01
Acc-no: 0001636050-21-000091 (34 Act) Size: 237 KB |
2021-11-12 | 001-37418 211398869 |
| 8-K | Documents Interactive Data | Current report, items 7.01, 8.01, and 9.01
Acc-no: 0001636050-21-000087 (34 Act) Size: 229 KB |
2021-11-01 | 001-37418 211365278 |
| 8-K | Documents Interactive Data | Current report, items 5.02 and 9.01
Acc-no: 0001636050-21-000084 (34 Act) Size: 186 KB |
2021-10-21 | 001-37418 211337661 |